arrow
B

Bartłomiej Tomasik

Medical University of Gdańsk
H指数:19
被引数:1,197

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of single-fraction stereotactic body radiotherapy (SBRT) for the curative treatment of extracranial primary Tumors: A collaborative systematic review on behalf of the SBRT focus Group of the European Society for Radiotherapy & Oncology (ESTRO)

单次分割立体定向体部放射治疗(SBRT)治疗颅外原发性肿瘤的疗效与安全性:欧洲放射治疗与肿瘤学会(ESTRO)SBRT重点小组的协作系统综述

2026-10-010
OA
Diagnostic Accuracy of Amino Acid PET for Differentiating Tumor Recurrence or Progression from Treatment-Related Changes in Glioma Patients: A Uppstematic Review and Meta-Analysis

氨基酸PET诊断胶质瘤患者肿瘤复发或进展与治疗相关变化的准确性:一项系统评价和荟萃分析

Cancers
IF4.4
2026-09-230
OA
Understanding retention in radiation oncology: quantitative findings from the retention survey by the ESTRO Early Career Committee

理解放射肿瘤学领域的留任问题:ESTRO早期职业委员会留任调查的定量发现

2026-08-050
PRE
Circulating microRNAs as prognostic biomarkers in patients with oropharyngeal cancer undergoing radiotherapy: temporal dynamics analysis

循环microRNAs作为接受放疗的口咽癌患者的预后生物标志物:时间动态分析

2026-07-180
OA
Integration of Patient-Reported Outcome Measures in Clinical Practice for Head and Neck Cancer Patients: A Cross-Sectional Survey

头颈癌患者临床实践中患者报告结局测量的整合:一项横断面调查

2026-05-090
OA
Stereotactic arrhythmia radioablation for refractory ventricular tachycardia: the STOPSTORM.eu study

立体定向心律失常放射消融治疗难治性室性心动过速:STOPSTORM.eu研究

2026-04-200
OA
Evaluating Quality of Life in Thoracic Malignancy Trials: A scoping review on ESMO-MCBS Quality of Life Checklist Adherence and Concordance With Progression-Free and Overall Survival

评估胸部恶性肿瘤试验中的生活质量:关于ESMO-MCBS生活质量清单依从性及其与无进展生存期和总生存期一致性的范围综述

2026-04-030
OAAI
Serum citrulline as a prognostic marker in patients with oropharyngeal carcinoma treated with chemoradiotherapy

血清瓜氨酸作为接受放化疗的口咽癌患者的预后标志物

2026-01-010
PRE
Clinical evidence and reporting standards in reirradiation: Insights from 28 studies at ESTRO 2025, endorsed by the ESTRO reirradiation focus group

再放疗的临床证据与报告标准:来自ESTRO 2025年会上28项研究的见解,并由ESTRO再放疗重点小组认可

2025-12-010
OAAI
Analyzing Cardiorespiratory Motion and Its Dosimetric Effect on Stereotactic Arrhythmia Radio-Ablation: A STOPSTORM.eu Consortium Study

分析心肺运动及其对立体定向心律失常放射消融的剂量学影响:一项STOPSTORM.eu联盟研究

2025-10-280
OAAI
Long-term outcomes from pembrolizumab monotherapy in patients with advanced NSCLC, PD-L1 expression ≥ 50 %, and poor performance status: Transformer-based AI to characterize prognostic complexity

长期接受帕博利珠单抗单药治疗的患者中,具有晚期非小细胞肺癌、PD-L1表达≥50%且体力状况较差者的长期结局:基于Transformer的AI用于表征预后复杂性

2025-10-160
OAAI
Characterizing epithelial-mesenchymal transition-linked heterogeneity in breast cancer circulating tumor cells at a single-cell level

在单细胞水平上表征乳腺癌循环肿瘤细胞中与上皮-间质转化相关的异质性

2025-10-010
OAAI
Auto-contouring of cardiac substructures for Stereotactic arrhythmia radioablation (STAR): A STOPSTORM.eu consortium study

用于立体定向心律失常放射消融 (STAR) 的心脏子结构的自动轮廓: STOPSTORM。欧盟财团研究

2025-01-012
OAAI
Professional development through mentoring: Final evaluation of the pilot mentoring programme of the European society of radiotherapy and oncology
2024-06-013
OAAI